Insulet [PODD] - Last Close: $189.48
News of an insider buy is boosting shares of Insulet.
According to a Form 4 filing, President & CEO James Hollingshead purchased 5,500 shares of PODD for a total price of about $1 million.
Hollingshead now directly controls a total of 34,177 shares of the company, bringing his stake to about 4.89%.
PODD is leading the S&P 500 with a 4.4% gain in today's premarket.
My Take: PODD has had a rough few months, but it could be on the verge of potentially bottoming out if it can maintain its recent bout of positive momentum.
Tingo Group [TIO] - Last Close: $0.8497
Tingo Group is trending after firing back at a short seller.
The FinTech firm was the subject of a recent report from notorious short seller Hindenburg Research, who accused the company of various misdeeds.
Upon publishing of the report, Tingo Group launched a full investigation into Hindenburg's accusation, and it just published its findings early this morning.
The report explored several points cited in the Hindenburg report and provided appropriate explanations.
Now, Tingo will begin an investigation into accusations against the company's founder, Dozy Mmobousi.
TIO is up 27.1% in response to the report.
My Take: I don't know enough about the Hindenburg report to tell you whether TIO made a strong defense against the accusations. However, the stock's movement today seems to indicate the investigation reassured at least some bullish investors.
AgeX Therapeutics [AGE] - Last Close: $0.7201
AgeX Therapeutics is trending after a merger announcement.
The biotech company has agreed to an all-stock merger agreement with privately-held Serina Therapeutics.
Under the terms of the deal, Serina shareholders will receive shares of AgeX common stock and will own 75% of the combined company upon closing.
AGE shareholders will be issued post-merger warrants, and they will receive additional incentive warrants if they exercise their post-merger warrants.
The deal is expected to close sometime in Q1 2024, pending customary closing conditions and shareholder approval.
AGE is up 12.4% in early premarket trading.
My Take: This is an unusual merger deal, but it appears to be an overall positive for AGE. However, it's not a game-changer, so I don't expect to see any more dramatic moves in the near future.
AgileThought [AGIL] - Last Close: $0.155
AgileThought is reversing course in dramatic fashion.
The IT services stock is rebounding from a recent slide in the wake of a recently-released analyst note.
Yesterday, Cantor Fitzgerald analyst Josh Siegler reiterated his neutral rating on AGIL and maintained a price target of $2.
The analyst note came just a day after AgileThought filed for Chapter 11 bankruptcy and announced plans to go private.
This morning, AGIL is the top-performing stock, with a 108.3% gain in the premarket.
My Take: This move doesn't really add up in my mind. I have a hunch this could be a pump and dump, so don't get caught holding the bag.
